Total Valuation
Psyence Biomedical has a market cap or net worth of $11.60M. The enterprise value is -$6.08M.
Market Cap$11.60M
Enterprise Value-$6.08M
Share Statistics
Psyence Biomedical has 3,814,328 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,814,328
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Psyence Biomedical’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -36.81%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-36.81%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-578.04K
Employee Count12
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Psyence Biomedical is ―. Psyence Biomedical’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Psyence Biomedical had revenue of 0.00 and earned -6.94M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-6.24M
Pretax Income-6.94M
Net Income-6.94M
EBITDA-6.92M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.05M and capital expenditures -8.00, giving a free cash flow of -1.05M billion.
Operating Cash Flow-1.05M
Free Cash Flow-1.05M
Free Cash Flow per Share-0.28
Dividends & Yields
Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.93
52-Week Price Change-90.08%
50-Day Moving Average4.55
200-Day Moving Average8.51
Relative Strength Index (RSI)39.53
Average Volume (3m)1.12M
Important Dates
Psyence Biomedical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Psyence Biomedical as a current ratio of 14.62, with Debt / Equity ratio of 0.00%
Current Ratio14.62
Quick Ratio14.62
Debt to Market Cap0.00
Net Debt to EBITDA1.08
Interest Coverage Ratio-655.06
Taxes
In the past 12 months, Psyence Biomedical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Psyence Biomedical EV to EBITDA ratio is 1.08, with an EV/FCF ratio of 0.86.
EV to Sales0.00
EV to EBITDA1.08
EV to Free Cash Flow0.86
EV to Operating Cash Flow0.91
Balance Sheet
Psyence Biomedical has $733.00 in cash and marketable securities with $10.45K in debt, giving a net cash position of -$9.71K billion.
Cash & Marketable Securities$733.00
Total Debt$10.45K
Net Cash-$9.71K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―